Krka group net down 5% in 2015 as sales stagnate
Novo Mesto, 3 March - Drug maker Krka reported a group net profit of just over EUR 158m for 2015, down 5% over the year before. Revenue declined by 2% to EUR 1.16bn, despite an uptick in volume sales, according to unaudited results released on Thursday.
The rest of this news item is available to subscribers.
The news item consists of 1.326 characters (without spaces) or 273 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.